The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Regional Reporting Structure

4 Oct 2018 07:01

RNS Number : 9111C
Electrocomponents PLC
04 October 2018
 

New Regional Reporting Structure

Electrocomponents issues a restatement of its financial results for the year ended 31 March 2018 and for the half year ended 30 September 2017. We announced at our final results in May that we would be moving to a new simpler structure with three regions: EMEA, Asia Pacific and the Americas. In order to drive further accountability, we have also taken the opportunity to move a greater proportion of cost that had previously been charged in central costs out to the regions. These include costs such as regional recruitment costs, pensions and share-based payment costs.

This does not change the Group's revenue or adjusted operating profit. The table below restates our segmental analysis onto the new structure.

EMEA(1)

Asia Pacific

Americas

Group

£m

£m

£m

£m

Six months to 30 September 2017 (restated)

Revenue

511.3

89.7

222.8

823.8

Segmental operating profit / (loss)

73.5

(3.9)

25.9

95.4

Central costs

(14.2)

Adjusted operating profit

81.2

Year to 31 March 2018 (restated)

Revenue

1,083.5

181.0

440.8

1,705.3

Segmental operating profit / (loss)

161.1

(0.9)

51.4

211.5

Central costs

(34.4)

Adjusted operating profit

177.1

 

The table below restates our like-for-like growth rates for this year.

Like-for-like revenue growth(2)

Regions

Q1 to June 2018

Q2 to Sept 2018

H1 to Sept 2018

EMEA

9%

10%

9%

Asia Pacific

10%

9%

10%

Americas

13%

9%

11%

Group

10%

10%

10%

 

Enquiries:

David Egan

Group Finance Director

0207 239 8400

Polly Elvin

Head of Investor Relations & Corporate PR

0207 239 8427

Martin Robinson/David Allchurch

Tulchan Communications

0207 353 4200

 

Notes:

1. EMEA will include the sub-regions Northern Europe, Southern Europe and Central Europe, as well as our emerging market operations, which had previously been in the Asia Pacific region.

2. Like-for-like change excludes the effects of changes in exchange rates on translation of overseas operating results, with 2018 converted at 2019 average exchange rates for the period, and the impact of acquisitions. Revenue is also adjusted to eliminate the impact of trading days year on year.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAPEDEDAPFFF
Date   Source Headline
11th Sep 20208:50 amRNSDirector Declaration
7th Sep 20204:06 pmRNSDirector/PDMR Shareholding
2nd Sep 20201:58 pmRNSDirector/PDMR Shareholding
1st Sep 202010:57 amRNSTotal Voting Rights
3rd Aug 20209:52 amRNSBlock listing Interim Review
16th Jul 20204:53 pmRNSResult of AGM
7th Jul 20207:00 amRNSTrading Statement
1st Jul 20204:03 pmRNSDirector/PDMR Shareholding
1st Jul 202010:04 amRNSTotal Voting Rights
23rd Jun 20209:30 amRNSNotice of Trading Update
16th Jun 202012:59 pmRNSAnnual Financial Report
10th Jun 20204:37 pmRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSFinal Results
4th May 202010:00 amRNSNotice of 2020 Full-Year Results
1st May 20209:46 amRNSTotal Voting Rights
30th Apr 202012:20 pmRNSDisclosure of Rights Attached to Ordinary Shares
1st Apr 20209:33 amRNSTotal Voting Rights
27th Mar 20209:00 amRNSAdditional Listing
23rd Mar 20207:00 amRNSTrading Statement
12th Mar 202012:24 pmRNSDirector/PDMR Shareholding
12th Mar 202011:45 amRNSDirector/PDMR Shareholding
5th Mar 20203:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20209:55 amRNSTotal Voting Rights
4th Feb 20207:01 amRNSDirector illness
4th Feb 20207:00 amRNSTrading Statement
3rd Feb 20209:01 amRNSBlock listing Interim Review
3rd Feb 20209:00 amRNSTotal Voting Rights
23rd Jan 202010:30 amRNSNotice of Trading Update
2nd Jan 20209:00 amRNSTotal Voting Rights
16th Dec 20193:41 pmRNSDirectorate Change
2nd Dec 20199:00 amRNSTotal Voting Rights
27th Nov 201910:30 amRNSValue-added solutions investor day
12th Nov 20197:00 amRNSHalf-year Report
11th Nov 20197:00 amRNSDirector illness
1st Nov 20199:00 amRNSTotal Voting Rights
10th Oct 201910:00 amRNSDirector Declaration
8th Oct 20197:00 amRNSTrading Statement
1st Oct 201912:30 pmRNSTotal Voting Rights
24th Sep 20191:05 pmRNSDirectorate Change
24th Sep 201911:01 amRNSNotice of Trading Update
2nd Sep 201912:54 pmRNSDirectorate Change
2nd Sep 201911:41 amRNSBlock listing Interim Review
2nd Sep 201911:27 amRNSTotal Voting Rights
23rd Aug 20199:00 amRNSHolding(s) in Company
1st Aug 201910:01 amRNSTotal Voting Rights
26th Jul 20192:28 pmRNSElectrocomponents plc signs private placement
24th Jul 201910:41 amRNSDirector/PDMR Shareholding
19th Jul 201910:09 amRNSDirector/PDMR Shareholding
17th Jul 201912:05 pmRNSResult of AGM
15th Jul 20194:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.